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AbstrACt
Introduction In mechanically ventilated patients, sedation 
strategies are a major determinant of outcome. The 
emergency department (ED) is the earliest exposure to 
mechanical ventilation for hundreds of thousands of patients 
annually in the USA. The one retrospective study that exists 
regarding ED sedation for mechanically ventilated patients 
showed a strong association between deep sedation in the 
ED and worse clinical outcomes. This finding suggests that 
the ED may be an optimal location to study the impact of 
early sedation on outcome, yet a lack of prospective studies 
represents a knowledge gap in this arena. This protocol 
describes a prospective observational study aimed at further 
characterising ED sedation practices and assessing the 
relationship between ED sedation and clinical outcomes. 
An association between ED sedation and clinical outcomes 
across multiple sites would suggest the need for changes in 
the current sedation strategies used in the ED, and provide 
evidence for future interventional studies in this field.
Methods and analysis This is a multicentre, prospective 
cohort study testing the hypothesis that deep sedation in the 
ED is associated with worse clinical outcomes. A cohort of 
over 300 mechanically ventilated ED patients will be included. 
The primary outcome is ventilator-free days, and secondary 
outcomes include hospital mortality, incidence of acute 
brain dysfunction and lengths of stay. Multivariable linear 
regression will test the hypothesis that deep sedation in the 
ED is associated with a decrease in ventilator-free days.
Ethics and dissemination Approval of the study by the 
Institutional Review Board (IRB) at each participating site has 
been obtained prior to data collection on the first patient. This 
work will be disseminated by publication of peer-reviewed 
manuscripts, presentation in abstract form at scientific 




Provision of analgesia and sedation is ubiq-
uitous in the care of mechanically ventilated 
patients. While sedation was historically 
viewed as a means to adapt the patient to the 
ventilator and facilitate care, recent studies 
demonstrate that sedation strategies (eg, 
depth of sedation and medications delivered) 
are highly influential on clinical outcomes 
in mechanically ventilated patients.1 2 Given 
this, guidelines for intensive care unit (ICU) 
sedation recommend: (1) maintaining light 
levels of sedation unless clinically contrain-
dicated; (2) objectively monitoring depth of 
sedation; (3) using non-benzodiazepine seda-
tion strategies and (4) routinely monitoring 
for the presence of delirium.1
The majority of data in this domain comes 
from randomised controlled trials (RCTs) 
which enrolled patients after 48–96 hours 
of mechanical ventilation, or observational 
data centred on an entire ICU stay.3 The 
early period of mechanical ventilation (ie, 
in the emergency department (ED) and first 
strengths and limitations of this study
 ► This study is the first to examine prospectively the 
impact of emergency department (ED) sedation on 
clinical outcomes.
 ► The observational design will allow the enrolment 
of a large sample of diverse patients, which will add 
significantly to the knowledge base regarding cur-
rent ED sedation practices.
 ► The multicentre nature of the study will increase ex-
ternal validity of the findings.
 ► An observational design can only describe associa-
tions and not causation.
 ► The study will rely on real-world assessments and 
documentation of sedation depth and the presence 
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48 hours in ICU) has been largely ignored, yet may be 
particularly influential on outcome.4 In the most compre-
hensive evaluation of the world’s literature to date, our 
group previously showed a strong association between 
early (within 48 hours of instituting mechanical ventila-
tion) sedation depth and outcome.3 Early light sedation 
was associated with lower hospital mortality (9.2%) versus 
deep sedation (27.6%) (OR 0.34, 95% CI 0.21 to 0.54), 
p<0.001. The frequency of delirium was 28.7% in lightly 
sedated patients versus 48.4% in the deep sedation group 
(p=0.11). Early light sedation was also associated with 
fewer mechanical ventilator days (mean difference, −2.1 
(95% CI −3.6 to −0.5), p=0.008) and shorter ICU lengths 
of stay (mean difference, −3.0 days (95% CI −5.4 to −0.6)), 
p=0.02.3 This systematic review and meta-analysis also 
identified a critical knowledge gap regarding early seda-
tion and its potential impact on outcome, as the majority 
of data was from retrospective cohort studies, and only 
two pilot RCTs (n=97 patients) have been conducted.5 6
The ED is the most proximal time period of mechanical 
ventilation for many critically ill patients, yet little atten-
tion has been given to the impact that ED-based sedation 
may have on outcome. Our preliminary data suggest that 
the ED may be an optimal location to study the impact 
of early sedation for several reasons.7 First, deep sedation 
in the ED is common (64%), with a median Richmond 
Agitation-Sedation Scale (RASS) of −3.0 (−4.0 to −2.0). 
Evidence shows that this early oversedation can extend for 
days in the ICU (sedation overshoot).8 This fact, paired 
with our data, suggests that an ED-based goal-oriented 
sedation intervention could not only reduce the negative 
effects of deep sedation in the ED, but reduce sedation 
overshoot early in the ICU as well. Second, deep sedation 
in the ED is associated with higher mortality, and more 
ventilator and ICU days.7 Third, approximately two-thirds 
of mechanically ventilated ED patients receive benzodi-
azepines, a strategy shown to increase the incidence of 
delirium, as well as the duration of mechanical ventila-
tion and ICU length of stay. Targeting early sedation in 
the ED seems needed, and may be an effective strategy to 
reduce complications in this vulnerable cohort. This has 
not been a topic of previous research.
In addition to the clinical outcome data mentioned 
above, there is strong biological rationale for the avoid-
ance of deep sedation by targeting the ED. Not only does 
sedation exert profound effects on the brain, preclinical 
data demonstrate that sedation has negative pleiotropic 
effects on other organ systems. In the gastrointestinal 
tract, sedatives and opiates can imbalance the micro-
biome, compromise intestinal barrier function, induce 
bacterial translocation and increasing microbial viru-
lence.9 In the microcirculation, deep sedation induces 
deterioration in vasomotor function and response to 
ischaemia, suggesting sedation strategy could affect 
tissue perfusion at the microcirculatory level.10 In the 
immune system, sedatives can inhibit neutrophil and 
macrophage function, decrease bacterial clearance and 
increase mortality in infected animals.11–17 Significant to 
the paradigm of early deep sedation, these immunomod-
ulatory effects can be seen early, within 1–2 hours.18
The data regarding ED sedation only exist from our 
centre. It is unknown if our results are generalisable to 
other EDs, and this represents a significant knowledge 
gap. Therefore, prior to the planning of any potential 
interventional studies, we feel it important to further 
investigate the current state of ED sedation in critically 
ill mechanically ventilated patients. Given the clinical 
outcome data associated with early sedation, as well as the 
preliminary ED-based data from our centre, we designed 
this study with the objectives to: (1) further characterise 
modern ED sedation practices across multiple sites and 




To assess the relationship between ED sedation (depth 
and agents used) and clinical outcomes. We hypothesise 
that deep sedation in the ED will be independently associ-
ated with significant differences in clinical outcomes after 
admission to the ICU.
Aim 2
To characterise ED sedation practices for mechanically 
ventilated patients across a diverse cohort of academic 
institutions.
significance
It is likely that sedation in mechanically ventilated patients 
is highly influential on patient-centred outcomes, such 
as ventilator-free days, mortality, delirium incidence and 
lengths of stay. Accurate assessment of ED sedation and 
improved understanding of outcomes associated with ED 
sedation can help guide decision making, improve patient 
care and assist in the planning of future clinical studies. It 
appears to be common for patients to be deeply sedated 
in the ED, which is discordant with ICU-based guideline 
recommendations.1 7 However, it is possible that sedation 
requirements and approaches may be distinctly different 
in the ED from those in the ICU, and existing guidelines 
may not be applicable. Our initial data show that ED-based 
sedation could be highly influential on outcome. Going 
forward, a strong association between ED sedation and 
clinical outcomes across multiple sites would suggest the 
need for changes in the current standard of care in the 




This is a multicentre, prospective cohort study. Using 
a cross-sectional approach, data for each centre will be 
collected during a 1-month time period between 1 June 
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study population
The target population for this study is mechanically venti-
lated patients in the ED. Inclusion criteria are: (1) receipt 
of invasive mechanical ventilation in the ED. Exclusion 
criteria are: (1) death or discontinuation of mechanical 
ventilation within 24 hours of presentation; (2) transfer 
to another hospital from the ED; (3) presence of neuro-
logical injury as the indication for mechanical ventila-
tion (eg, acute cerebrovascular accident, traumatic brain 
injury, status epilepticus or sudden cardiac arrest) and 
(4) chronic/home mechanical ventilation. Presence of 
neurological injury is an exclusion criterion as patients 
with neurological injury can have depressed levels of 
consciousness that is independent of sedation, and there-
fore serve as a confounder between sedation depth and 
clinical outcomes. Patients on chronic/home ventilation 
may require vastly different sedation approaches (ie, no 
sedation at all), given their chronic condition. Also, the 
ability to calculate ventilator-free days in these patients 
may not be possible.
Patients will be recruited exclusively from the ED, and 
enrolled without regard to gender or race. Based on the 
multicentre nature of this study, and the demographics 
of the patient population routinely presenting to the ED, 
we expect a diverse patient population. We, therefore, 
expect that the study findings will hold external validity 
and be applicable to the community as a whole.
Patient and public involvement
The patients in this study were not involved in the devel-
opment of the research question or study design, and will 
not be involved in recruitment or conduct of the study.
data
We anticipate collecting the following baseline charac-
teristics: age, gender, race, weight, height, pre-existing 
comorbid conditions, vital signs at presentation and perti-
nent laboratory variables. Illness severity will be assessed 
with the modified Sequential Organ Failure Assessment 
(SOFA) score. This omits the Glasgow Coma Scale (GCS) 
component of the SOFA score, which has poor inter-
rater agreement; it is also collinear to measurements of 
sedation depth.19–21 Comorbid conditions will include: 
dementia, diabetes mellitus, cirrhosis, congestive heart 
failure, end-stage renal disease, chronic obstructive 
pulmonary disease, immunosuppression, malignancy, 
alcohol abuse and history of psychiatric illness (eg, schizo-
phrenia, bipolar, major depression or anxiety).
ED process of care variables will include: ED length 
of stay, blood product transfusion, antibiotics, central 
venous catheter placement and vasopressor infusion. 
Data related to mechanical ventilation will include: loca-
tion of intubation (ie, prehospital or ED), indication for 
mechanical ventilation, ventilator mode, tidal volume, 
positive end-expiratory pressure, set respiratory rate, frac-
tion of inspired oxygen, peripheral oxygen saturation, 
peak airway pressure and inspiratory plateau pressure.
Data related to sedation in the ED will include: neuro-
muscular blockers and induction agents administered to 
facilitate endotracheal intubation. Subsequent medica-
tions related to analgesia and sedation in the ED will also 
be collected, and will include: opiates, benzodiazepines, 
propofol, ketamine, dexmedetomidine, etomidate, halo-
peridol, quetiapine and neuromuscular blocking agents. 
Medications administered for the management of anal-
gosedation during the first 48 hours of ICU admission will 
also be collected. All antipsychotic agents, such as queti-
apine and haloperidol, will be collected.
Sedation depth in the ED will be recorded. It is 
recognised that multiple sedation scales exist for moni-
toring sedation depth in mechanically ventilated patients. 
Given the observational and pragmatic design of the study, 
sedation depth will be monitored according to the stan-
dard operating procedures already in place at an existing 
site. This may include monitoring of sedation depth with 
scales such as the (RASS; deep sedation defined as a score 
of −3 to −5; preferential scale) or the Riker Sedation-Ag-
itation Scale (deep sedation defined as a score of 2 or 
1).22 If more than one sedation depth per patient is docu-
mented in the ED, then the median value will be used.7
As sedation in the ED for mechanically ventilated 
patients has not been a research or clinical focus until 
recently, it is also recognised that some EDs may not have 
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protocols in place to routinely monitor sedation depth. In 
this situation, we will use surrogates for depth of sedation, 
which include a documented GCS (GCS <9 defined as 
deep sedation).23 In patients for whom no sedation depth 
is documented in the ED, the first ICU RASS will be used 
as a surrogate for the ED depth of sedation, provided 
that it is measured within the first 3 hours of ICU admis-
sion, congruent with our prior approach.7 Use of an early 
ICU RASS score as a reliable surrogate for ED RASS is 
supported by previous data demonstrating that sedation 
depth remains relatively static during the first 24 hours of 
ICU admission.4
Pertinent clinical data after admission, including the 
first 48 hours of ICU sedation depth, will also be included. 
Table 1 shows a full description of events for this study.
outcomes
Patients will be followed until hospital discharge or 
death. The primary outcome of interest is ventilator-free 
days. Secondary outcomes include all cause in-hospital 
mortality, the presence of acute brain dysfunction during 
the first 48 hours in the ICU, as well as ICU-free and 
hospital-free days.
Acute brain dysfunction is a composite outcome 
composed of delirium and coma. Delirium will be 
assessed by the Confusion Assessment Method for the 
ICU (CAM-ICU) per local institutional protocols. This 
is a highly reproducible and well-validated method for 
diagnosing delirium in mechanically ventilated patients. 
Coma will be defined as having all documented RASS (or 
equivalent sedation scale) scores of −4 (responsive to only 
physical stimulus) or −5 (unresponsive) during the first 
48 hours. We elect to use this composite outcome since 
both delirium and coma are major categories of cogni-
tive dysfunction. As delirium cannot be assessed during 
periods of coma, using this composite outcome provides a 
more accurate event rate for the incidence of acute organ 
dysfunction of the brain. This secondary outcome will be 
assessed at 48 hours for two reasons: (1) early sedation 
within this time frame has been strongly associated with 
clinical outcome in the ICU4 24 25 and (2) initial sedation 
approach often extends into this time period, providing a 
temporal link to the sedation provided in the ED.7 8
Clinical outcomes will be assessed as a function of ED 
sedation depth, with the a priori hypothesis being that 
deep sedation will be associated with fewer ventilator-free 
days, higher mortality, a greater incidence of acute brain 
dysfunction and longer lengths of stay.
Descriptive outcomes include the sedative and anal-
gesic medications administered in the ED. By assessing 
this descriptive outcome, we will further characterise 
ED-based sedation and assess potential targets for future 
investigation. We will also describe early ICU sedation 
practices during the first 48 hours after admission. If early 
ICU sedation appears to be influenced by the initial seda-
tion approach in the ED, this provides further rationale 
that the ED should be the starting point and target for 
future studies.
Proposed statistical methods
Patient characteristics will be assessed with descriptive 
statistics and frequency distributions. Categorical char-
acteristics will be compared using the χ2 test or Fisher’s 
exact test. Continuous characteristics will be compared 
using the independent samples t-test or Wilcoxon’s 
rank-sum test.
The primary analysis will examine ventilator-free days 
as a function of ED sedation depth. A multivariable linear 
regression model will be constructed to adjust for poten-
tially confounding variables using backward elimination. 
A priori baseline characteristics with known prognostic 
significance for mortality in ED mechanically ventilated 
patients will be included in the model. Other clinically 
relevant and biologically plausible variable that are statis-
tically significant in univariate analysis at a p<0.10 level 
will also be included in the model. Collinearity will be 
assessed and the model will use variables that are statis-
tically independent of other variables. All tests will be 
two tailed, and a p<0.05 will be considered statistically 
































ED ventilator data X
ED sedation data X
Depth of sedation* X X X









*Preferentially assessed with RASS Score; SAS or GCS may also 
be used, per local institutional procedures.
CAM, confusion assessment method; ED, emergency department; 
GCS, Glasgow Coma Scale; ICU, intensive care unit; RASS, 
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significant. Time (in days) to mortality will be assessed 
with the Kaplan-Meier survival estimate and log-rank test, 
comparing the deep sedation and light sedation groups.
We will conduct a priori subgroup analyses to further 
understand the treatment effect and identify subgroups 
in which heterogeneous treatment effects exist. These 
subgroups will be based on (but are not limited to): 
illness severity, indication for mechanical ventilation 
and specific medications received in the ED or ICU (eg, 
benzodiazepines, dexmedetomidine). On study comple-
tion, additional analyses may be performed post hoc if 
they are believed to contribute valuable or novel informa-
tion, or if unforeseen imbalances in the data are present.
sample size
We estimate our sample size calculation based on prior 
work from the ICU which reported the impact of seda-
tion on ventilator-free days,26–29 a cohort study regarding 
early sedation depth and its impact on outcome,4 and 
our single-centre cohort study examining the impact 
of ED sedation depth on clinical outcome.7 We conser-
vatively estimated a difference in mean (SD) venti-
lator-free days of 2.5 between the two groups: deep 
sedation (18.5 (8.0)) vs light sedation (21.0 (8.0)). For 
80% power and a α of 0.05, we will need a total sample 
size 324 patients (162 per group). Based on our prior 
work involving mechanically ventilated patients in the 
ED, we expect approximately 0.75–1.0 patients to satisfy 
inclusion and exclusion criteria per site, each day.30 31 
With 16 centres agreeing to participate, we expect a total 
sample size that is capable of achieving the objectives of 
this investigation.
Anticipated results
We anticipate that deep sedation in the ED will be 
common, as will the use of benzodiazepines for postintu-
bation sedation. We also anticipate that the presence of 
deep sedation in the ED will be associated with a reduc-
tion in ventilator-free days, higher mortality and a greater 
incidence of acute brain dysfunction and longer lengths 
of stay.
data storage and management
All data will be entered by site principal investigators (PI) 
or research assistants and data accuracy will be verified by 
the study PI. Data quality control measures will include 
queries to identify missing data, outliers and discrepan-
cies. Only research assistants and site PIs will have access to 
protected health information. After enrolment, a unique 
identifier will be assigned to each study subject. The data 
from all sites will be uploaded and stored using Research 
Electronic Data Capture, a web-based data management 
application. All computers will be password protected 
and encrypted per university policy. The PI will ensure 
that the anonymity is maintained. Patients will not be 
identified by name in any reports on this study. The study 
PI will have access to the final study dataset.
EthICs And dIssEMInAtIon
dissemination and data sharing
To enhance reporting transparency, this study will be 
reported in accordance with the Strengthening the 
Reporting of Observational Studies in Epidemiology State-
ment: Guidelines for Reporting Observational Studies.32
Data and resources will be shared with other eligible 
investigators through academically established means. 
The datasets used and/or analysed during the study will 
be available from the corresponding author on reason-
able request. Collaboration with others investigators 
interested in optimising outcomes for mechanically venti-
lated patients in the ED will be welcomed. The results 
from this work will be published as a full-length, peer-re-
viewed manuscript and presented at national meetings.
strengths and limitations
Strengths
Currently, only one retrospective cohort study has been 
published regarding the impact of ED sedation on clin-
ical outcome.7 The current investigation will add a signif-
icant amount of data to this research domain. Further, it 
will address some of the prior weaknesses in this field: (1) 
the multicentre nature of the study will enhance external 
validity of the findings and (2) it will prospectively enrol 
patients and capture data. This will allow us to track seda-
tion depth as a potential function of illness severity or 
neurological status with more accuracy, reducing poten-
tial confounders related to sedation depth.
Limitations
This study will have several limitations. As an observational 
study, it will only be able to demonstrate associations and 
not causation. We will attempt to enhance causal inference 
in several ways. We will apply a rigorous multivariable anal-
ysis to address potential confounders. A scientific gap will be 
addressed by enrolling across multiple sites and we will check 
the consistency of our results with prior work in this field. 
Finally, we will report all results transparently in accordance 
with guideline recommendations, which have been shown 
to improve reporting in observational studies.32 The obser-
vational cohort study design is also prone to confounders, 
though this should be reduced somewhat by prospective 
data collection. We also will have to rely on real-world assess-
ments and documentation of sedation depth and the pres-
ence of delirium (CAM-ICU). While these assessments are 
part of standard ED and ICU protocols for mechanically 
ventilated patients, without dedicated study team members 
performing these assessments, there is potential for inac-
curacies. However, this does reflect daily practice and may 
enhance external validity of our findings. The collection 
of clinical data beyond 48 hours would be advantageous 
for the association between ED sedation depth and other 
clinical outcomes, such as organ failure and ICU-acquired 
infections. Finally, the intent of this investigation is not to 
produce definitive answers related to ED-based sedation 
and its impact on outcome, but rather to provide further 
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larger trials. In that regard, this multicentre  study could be 
pivotal in changing how sedation is employed in the ED.
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